<DOC>
	<DOC>NCT00675220</DOC>
	<brief_summary>This study is conducted in Asia. The aim of this observational study is to collect efficacy and safety data in diabetic patients with acute hyperglycemia using NovoRapid™ FlexPen™ as per normal clinical practice.</brief_summary>
	<brief_title>Observational Study to Assess the Efficacy and Safety of NovoRapid™ Flexpen™</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 1</mesh_term>
	<mesh_term>Insulin Aspart</mesh_term>
	<criteria>Patients with diabetes mellitus (according to product labelling) Hypoglycaemia Hypersensitivity to insulin aspart or to any of the excipients (according to product labelling)</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>